ArticleFrontiers in oncology2026
Primary diffuse large b-cell lymphoma of the lip: a case report and literature review.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Primary diffuse large B-cell lymphoma (DLBCL) of the lip is a rare subtype of extranodal non-Hodgkin lymphoma that presents a diagnostic challenge due to its infrequent location and nonspecific clinical symptoms. The early suspicion of this diagnosis is often delayed because of its overlap with benign inflammation/infection, such as abscesses and mucoceles. Case presentation: This report describes a 65-year-old male with worsening swelling of the upper lip that was initially diagnosed as a maxillary space infection. Imaging studies, including ultrasound and MRI, showed a poorly defined mass, and an axial biopsy with immunohistochemistry confirmed a diagnosis of the germinal center B-cell (GCB) subtype of DLBCL. The patient was ultimately treated successfully with R-CHOP chemotherapy and achieved complete remission. Conclusion: This case illustrates both the importance of considering lymphoma in the differential diagnosis of a lip lesion that has persisted and requires ongoing clinical evaluation, as well as the benefit of multidisciplinary care for appropriate diagnosis and timely management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.